CASINO: Low-Carbohydrate Diet and SGLT2-Inhibitor to Achieve Moderate Ketosis in Healthy Volunteers
-
Enrollment
This study is not currently enrolling. -
Research Area
Translational Research -
Location
-
Principal Investigator
-
Sponsor
AdventHealth CFD
The purpose of this study is to test the hypothesis that a low-carbohydrate diet combined with an SGLT2-inhibitor is sufficient to induce moderate ketosis in healthy volunteers.
To be enrolled in this study, you must meet certain requirements. You may be eligible to participate if you meet the following criteria:
Study Duration: Up to 10 weeks
Study Commitment: 1 screening visit (approximately 2-3 hours), 1 outpatient visit and a 29 day inpatient stay.
Age: 18-60 years old
Sex: Male & Female
Conditions/Eligibility: Male and Female aged 18-60
BMI 21-35 kg/m2
Overall healthy adult
Not a diabetic
Study Procedures: Screening process, which includes informed consent process, demographics, vitals, physical exam, urinalysis, blood draw, dexa scan.
1 outpatient visit which consists of standardized meals and randomization
29 full day inpatient stay which includes blood draws, vital signs, urine collections, low-carb diet consumption and administration of study medication, indirect calorimetry, and wearing a CGM
Compensation: Up to $10,000.
Please call
Call407-303-7193 or fill out the Contact Form below for more information.